CAFFEINE AUGMENTATION OF ELECTROCONVULSIVE SEIZURES

被引:30
作者
FRANCIS, A
FOCHTMANN, L
机构
[1] Department of Psychiatry and Behavioral Sciences, SUNY Stony Brook, Stony Brook, 11794, NY
关键词
CAFFEINE; ELECTROCONVULSIVE SHOCK; SEIZURE; RAT; ELECTROENCEPHALOGRAPHY; CONVULSIONS;
D O I
10.1007/BF02245072
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Caffeine has been used clinically to increase seizure length in electroconvulsive treatment (ECT). The present study was designed to establish an animal model of caffeine-augmented seizures for further study of mechanisms and effects of pharmacological manipulation of seizure length. Increasing doses of caffeine (0-200 mg/kg, IP) were given before electroconvulsive stimulation (ECS) in rats and resulting seizure lengths were quantified by timing of classical tonic-clonic convulsive movements. With this paradigm, caffeine led to a dose-dependent increase in seizure duration. This proconvulsant action of caffeine was detectable within 1 min after dosing, persisted for at least 230 min and was reversible. The results suggest that seizure length is a practicable measure in pharmacological modification of electroconvulsive seizures. They also suggest that pharmacologically-modified ECS can be modeled effectively in animals.
引用
收藏
页码:320 / 324
页数:5
相关论文
共 53 条
[31]   AUTORADIOGRAPHIC EVIDENCE FOR MULTIPLE CNS BINDING-SITES FOR ADENOSINE DERIVATIVES [J].
LEE, KS ;
REDDINGTON, M .
NEUROSCIENCE, 1986, 19 (02) :535-&
[32]   PURINERGIC INHIBITION OF DIAZEPAM BINDING TO RAT-BRAIN (INVITRO) [J].
MARANGOS, PJ ;
PAUL, SM ;
PARMA, AM ;
GOODWIN, FK ;
SYAPIN, P ;
SKOLNICK, P .
LIFE SCIENCES, 1979, 24 (09) :851-857
[33]   THE BRAIN RYANODINE RECEPTOR - A CAFFEINE-SENSITIVE CALCIUM RELEASE CHANNEL [J].
MCPHERSON, PS ;
KIM, YK ;
VALDIVIA, H ;
KNUDSON, CM ;
TAKEKURA, H ;
FRANZINIARMSTRONG, C ;
CORONADO, R ;
CAMPBELL, KP .
NEURON, 1991, 7 (01) :17-25
[34]   RELATIONSHIP BETWEEN CAFFEINE DISCRIMINATION AND CAFFEINE PLASMA-LEVELS [J].
MODROW, HE ;
HOLLOWAY, FA ;
CHRISTENSEN, HD ;
CARNEY, JM .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1981, 15 (02) :323-325
[35]   CAFFEINE AND THE CENTRAL-NERVOUS-SYSTEM - MECHANISMS OF ACTION, BIOCHEMICAL, METABOLIC AND PSYCHOSTIMULANT EFFECTS [J].
NEHLIG, A ;
DAVAL, JL ;
DEBRY, G .
BRAIN RESEARCH REVIEWS, 1992, 17 (02) :139-169
[36]  
SACKEIM H, 1987, ARCH GEN PSYCHIAT, V44, P355
[37]  
SANTAMBROGIO G, 1964, ARCH INT PHARMACOD T, V150, P259
[39]  
SAWYNOK J, 1993, PHARMACOL REV, V45, P43
[40]  
SHAPIRA B, 1987, AM J PSYCHIAT, V144, P1199